— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
TAMPA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Pacira Biosciences PCRX announced that the FDA has accepted for review its supplemental new drug application (sNDA) for Exparel. The sNDA seeks to expand Exparel’s label to include a single-dose ...
SAN DIEGO – Surgeons and anesthesiologists are increasingly resistant to using popliteal regional block anesthesia in foot and ankle surgery, but a recent study confirms that it is safe and effective ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Ultrasound-guided peripheral nerve blocks have a higher success rate compared to nerve stimulation or other methods, according to a study conducted by the Department of Anesthesiology at Johns Hopkins ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio VANCOUVER, British Columbia — Using ...
TAMPA, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback